CERES BRAIN Therapeutics

CERES BRAIN Therapeutics

Fabrication de produits pharmaceutiques

Paris, France 1 177 abonnés

CERES BRAIN aims to rescue neurons to treat neurological diseases

À propos

CERES BRAIN Therapeutics is dedicated to treat cerebral diseases with a first focus on rescuing suffering neurons with creatine through an innovative "creatine-to-brain" concept. The first indications are Creatine Transporter Deficiency syndrome, a disabling condition with no treatment affecting children and Amyotrophic Lateral Sclerosis. The lead compound CBT101 demonstrated efficacy in a preclinical models models as well as a large cerebral and neuronal distribution in primate. The CMC reached noticeable milestones with several GMP batches produced. Other mitochondriopathies are in the Ceres's pipeline. CERES BRAIN Therapeutics has already raised up to 12M€ to move towards the clinical program.

Secteur
Fabrication de produits pharmaceutiques
Taille de l’entreprise
2-10 employés
Siège social
Paris, France
Type
Société civile/Société commerciale/Autres types de sociétés
Fondée en
2019

Lieux

Employés chez CERES BRAIN Therapeutics

Nouvelles

Pages similaires

Parcourir les offres d’emploi